Ticker > Company >

Aster DM Healthcare share price

Aster DM Healthcare Ltd.

NSE: ASTERDM BSE: 540975 SECTOR: Hospital & Healthcare Services  1.37 L   209   68

619.30
-12.20 (-1.93%)
BSE: 15 Sep 04:01 PM

Price Summary

Today's High

₹ 635.95

Today's Low

₹ 613.6

52 Week High

₹ 674.15

52 Week Low

₹ 386.15

FinStar

Ownership Below Par
Stock price may face volatility due to ownership structure.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyExcellent
The company knows very well the utilization of its assets.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

32087.24 Cr.

Enterprise Value

31175.91 Cr.

No. of Shares

51.81 Cr.

P/E

114.06

P/B

8.37

Face Value

₹ 10

Div. Yield

19.86 %

Book Value (TTM)

₹  73.97

CASH

1288.71 Cr.

DEBT

377.38 Cr.

Promoter Holding

40.39 %

EPS (TTM)

₹  5.43

Sales Growth

13.94%

ROE

215.57 %

ROCE

175.02%

Profit Growth

3855.77 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Brands

These are the brands of Aster DM Healthcare Ltd.

MEDCARE ACCESS Medcity MIMS AADHAR HOSPITAL PRIME HOSPITAL

Index Presence

The company is present in 21Indices.

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year13.94%
3 Year27.62%
5 Year25%

Profit Growth

1 Year3855.77%
3 Year309.86%
5 Year152.4%

ROE%

1 Year215.57%
3 Year75.79%
5 Year45.62%

ROCE %

1 Year175.02%
3 Year63.53%
5 Year38.8%

Debt/Equity

0.1152

Price to Cash Flow

87.38

Interest Cover Ratio

69.9652

CFO/PAT (5 Yr. Avg.)

0.174654224753148

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Jun 2025 40.39 40.67
Mar 2025 41.89 40.67
Dec 2024 41.88 98.87
Sep 2024 41.88 98.87
Jun 2024 41.88 98.87
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good profit growth of 309.860856705732% for the Past 3 years.
  • The company has shown a good revenue growth of 27.6171960150867% for the Past 3 years.
  • Company has been maintaining healthy ROE of 75.7875333333333% over the past 3 years.
  • Company has been maintaining healthy ROCE of 63.5332666666667% over the past 3 years.
  • Company has a healthy Interest coverage ratio of 69.9652.
  • Company’s PEG ratio is 0.0295816707043236.
  • The company has an efficient Cash Conversion Cycle of -160.9318 days.
  • Company has a healthy liquidity position with current ratio of 3.8292.
  • The company has a strong degree of Operating leverage, Average Operating leverage stands at 50.5901349841355.

 Limitations

  • Tax rate is low at 1.2608.
  • The company is trading at a high EV/EBITDA of 48.2398.
  • Promoter pledging is high as 40.67%.

Quarterly Result (All Figures in Cr.)

PARTICULARS Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025
Net Sales 565.62 604.68 576.32 573.86 613.04
Total Expenditure 464.27 475.68 465.05 458.96 479.53
Operating Profit 101.35 129 111.27 114.9 133.51
Other Income 5619.51 46.74 37.29 35.13 38.43
Interest 21.43 19.34 21.55 23.25 21.64
Depreciation 34.64 36.57 35.55 37.76 37.88
Exceptional Items 372.7 0 -23.13 -26.42 -4.39
Profit Before Tax 6037.49 119.83 68.33 62.6 108.03
Tax 29.25 29.99 18.51 1.53 27.44
Profit After Tax 6008.24 89.84 49.82 61.07 80.59
Adjusted EPS (Rs) 120.28 1.8 1 1.22 1.56

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales 746.54 1116.47 1533.74 2036.5 2320.48
Total Expenditure 704.71 963.17 1240.66 1671.36 1858.35
Operating Profit 41.83 153.3 293.08 365.14 462.13
Other Income 21.63 82.2 49.77 49.02 5738.67
Interest 36.5 46.82 56.5 83.43 91.18
Depreciation 95 98.72 104.02 121.38 144.52
Exceptional Items 0 0 0 0 323.15
Profit Before Tax -68.04 89.96 182.33 209.35 6288.25
Tax 0.74 -0.22 9.04 52.39 79.28
Net Profit -68.78 90.18 173.29 156.96 6208.97
Adjusted EPS (Rs.) -1.38 1.81 3.47 3.14 124.3

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity and Liabilities
Share Capital 497.04 499.52 873.9 873.9 873.9
Total Reserves 2367.07 2455.69 2256.66 2420.34 2465.59
Borrowings 115.08 105.05 193.46 251.21 298.46
Other N/C liabilities 287.97 365.25 404.32 567.75 1012.65
Current liabilities 327.81 342.84 405.66 463.8 420.88
Total Liabilities 3594.97 3768.35 4134 4577 5071.48
Assets
Net Block 1008.9 1013.26 1008.29 1332.86 1760.44
Capital WIP 9.31 22.91 66.53 38.7 55.41
Intangible WIP 1.59 0 0.02 0.15 0
Investments 2150.65 2166.03 2141.1 719.68 1008.96
Loans & Advances 214.04 353.23 592.09 681.49 566.56
Other N/C Assets 12.23 13.14 11.09 34.28 68.49
Current Assets 198.25 199.78 314.88 1769.84 1611.62
Total Assets 3594.97 3768.35 4134 4577 5071.48
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Profit from operations -68.04 89.96 182.33 209.35 6288.25
Adjustment 131.89 71.5 118.19 167.33 -5857.29
Changes in Assets & Liabilities -12.72 -78.72 -38.89 67.82 2.72
Tax Paid -9.47 -4.4 -15.77 -31.75 -66.45
Operating Cash Flow 41.66 78.34 245.86 412.75 367.23
Investing Cash Flow -38.07 -49.17 -331.95 -342.32 6023
Financing Cash Flow -12.35 -17.69 92.2 -67.09 -6298.11
Net Cash Flow -8.76 11.48 6.11 3.34 92.12

Corporate Actions

Investors Details

PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
promoters 41.88 41.88 41.88 41.89 40.39
alisha moopen 0.04 0.04 0.04 0.05 0.05
azad moopen mandayapurath... 0.35 0.35 0.35 0.35 0.28
naseera azad 0.03 0.03 0.03 0.03 0.05
union (mauritius) holding... 4.00 4.00 4.00 4.00 3.86
union investments private... 37.41 37.41 37.41 37.41 36.06
zeba azad moopen 0.02 0.02 0.02 0.02 0.05
ziham moopen 0.03 0.03 0.03 0.03 0.03
PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
investors 58.12 58.12 58.12 58.11 59.61
bcp asia ii topco iv pte.... - - - - 2.69
franklin india smaller co... 2.70 3.29 3.25 2.92 2.74
hdfc small cap fund 6.16 6.62 6.84 6.88 6.63
kotak small cap fund - 2.14 2.80 3.40 4.14
llp 0.05 0.06 0.11 0.09 0.08
nippon life india trustee... 1.96 1.98 1.98 1.99 1.94
quant mutual fund - quant... - 1.39 2.09 2.27 2.19
rashid aslam bin mohideen... 2.25 2.25 2.25 2.25 2.17
rimco (mauritius) limited... 10.13 10.13 8.60 8.58 8.10
sbi contra fund 2.02 2.07 2.24 2.37 2.26
shamsudheen bin mohideenm... - - 1.13 1.14 1.09
smallcap world fund, inc 3.94 4.10 4.10 3.27 2.58
uti small cap fund - - - - 1.04
shamsudheen bin mohideen ... 1.13 1.13 - - -
icici prudential pharma h... 1.15 - - - -
morgan stanley asia (sing... 1.28 - - - -
olympus capital asia inve... 1.09 - - - -

Annual Reports

Title Link
Title Link
Annual Report 2024
Annual Report 2023
Annual Report 2022
Annual Report 2021
Annual Report 2020
Annual Report 2019
Annual Report 2018

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
Credit ICRA
Credit ICRA
Credit ICRA
Credit ICRA
Credit ICRA
Credit CRISIL
TYPE AGENCY Link
TYPE AGENCY Link
Research HDFC Securities
Research HDFC Securities
Research HDFC Securities
Research HDFC Securities
Research HDFC Securities
Research HDFC Securities
Research HDFC Securities

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
Concall Q4FY25
Concall Q3FY24
Concall Q3FY23
Concall Q3FY20
Concall Q2FY25
Concall Q2FY24
Concall Q1FY25
Concall Q1FY24
Concall Q1FY23
Concall Q1FY23
TYPE QUARTER Link
TYPE QUARTER Link
Presentation Q4FY23
Presentation Q4FY22
Presentation Q4FY21
Presentation Q4FY20
Presentation Q3FY25
Presentation Q3FY24
Presentation Q3FY22
Presentation Q3FY21
Presentation Q2FY25
Presentation Q2FY24
Presentation Q2FY24
Presentation Q2FY22
Presentation Q2FY21
Presentation Q1FY22
Presentation Q1FY21

Company News

Aster DM Healthcare informs about AGM 10 Sep, 12:19 PM Aster DM Healthcare informs about analyst meet 30 Aug, 3:41 PM Aster DM Healthcare submits BRSR 12 Aug, 9:46 AM Aster DM Healthcare informs about transcript of earnings conference 7 Aug, 5:34 PM Aster DM Healthcare informs about newspaper publications 7 Aug, 4:57 PM Aster DM Healthcare - Quaterly Results 30 Jul, 6:51 PM Aster DM Healthcare - Quaterly Results 30 Jul, 6:51 PM Aster DM Healthcare - Quaterly Results 30 Jul, 6:51 PM Aster DM Healthcare gets nod to acquire additional 13% stake in DRCM 30 Jul, 2:52 PM Aster DM Healthcare incorporates wholly owned subsidiary in Bengaluru 29 Jul, 9:38 AM Aster DM Healthcare incorporates wholly owned subsidiary in Bengaluru 23 Jul, 10:59 AM Aster DM Healthcare informs about allotment of equity shares 6 Jun, 5:01 PM Aster DM Healthcare - Quaterly Results 20 May, 6:34 PM Aster DM Healthcare - Quaterly Results 20 May, 6:34 PM Aster DM Healthcare to invest Rs 480 crore to set up multispecialty hospital in Bengaluru 8 May, 11:58 AM Aster DM Healthcare informs about disclosure 7 May, 12:14 PM Aster DM Healthcare signs lease agreement to set up new multi-specialty hospital 7 May, 10:21 AM Aster DM Healthcare completes acquisition of 5% stake in Quality Care India 30 Apr, 5:46 PM Aster DM Healthcare informs about allotment 29 Apr, 5:40 PM Aster DM Healthcare gets CCI’s approval for proposed merger with Quality Care India 16 Apr, 2:47 PM Aster DM Healthcare informs about disclosures 25 Mar, 12:44 PM Aster DM Healthcare informs about disclosure 25 Mar, 10:39 AM Aster DM Healthcare informs about change in senior management personnel 15 Mar, 11:36 AM Aster DM Healthcare informs about disclosure 11 Mar, 12:37 PM Aster DM Healthcare informs about disclosure 7 Mar, 12:51 PM Aster DM Healthcare informs about disclosure 28 Feb, 2:03 PM Aster DM Healthcare informs about disclosure 28 Feb, 11:56 AM Aster DM Healthcare informs about disclosure 27 Feb, 5:29 PM Aster DM Healthcare - Quaterly Results 31 Jan, 6:35 PM Aster DM Healthcare - Quaterly Results 31 Jan, 6:35 PM Aster DM Healthcare - Quaterly Results 31 Jan, 6:35 PM Aster DM Healthcare informs about change in SMP 23 Dec, 5:05 PM Aster DM Healthcare informs about credit rating 10 Dec, 5:19 PM Aster DM Healthcare informs about press release 29 Nov, 5:16 PM Aster DM Healthcare to acquire balance stake in Aster Aadhar Hospital 27 Nov, 2:26 PM Aster DM Healthcare informs about board meeting 27 Nov, 10:09 AM Aster DM Healthcare - Quaterly Results 23 Oct, 10:34 PM Aster DM Healthcare - Quaterly Results 23 Oct, 10:34 PM Aster DM Healthcare informs about compliance certificate 15 Oct, 10:31 AM Aster DM Healthcare’s arm inks pact to acquire 26% stake in Shri Sai Renew Venture Assets 1 LLP 4 Oct, 9:41 AM Aster DM Healthcare’s arm to set up new Aster Woman and Children Hospital in Hyderabad 23 Sep, 10:12 AM Aster DM Healthcare - Quaterly Results 31 Jul, 8:07 PM Aster DM Healthcare - Quaterly Results 31 Jul, 8:07 PM Aster DM Healthcare’s arm inks pact to acquire additional 25% stake in Usolar Assetco Two 20 Jul, 10:19 AM Aster DM Healthcare informs about presentation 17 Jun, 1:41 PM Aster DM Healthcare - Quaterly Results 28 May, 9:39 PM Aster DM Healthcare - Quaterly Results 28 May, 9:39 PM Aster DM Healthcare informs about press release 27 May, 2:41 PM Aster DM Healthcare to expand existing Aster CMI Hospital’s premises 27 May, 9:28 AM Aster DM Healthcare informs about compliance certificate 24 Apr, 6:15 PM

Aster DM Healthcare Stock Price Analysis and Quick Research Report. Is Aster DM Healthcare an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Aster DM Healthcare. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Aster DM Healthcare has a PE ratio of 113.783704140268 which is high and comparatively overvalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Aster DM Healthcare has ROA of 128.7036% which is a good sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Aster DM Healthcare has a Current ratio of 3.8292.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Aster DM Healthcare has a ROE of 215.569%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Aster DM Healthcare has a Debt to Equity ratio of 0.1152 which means that the company has low proportion of debt in its capital.

  • Sales growth: Aster DM Healthcare has reported revenue growth of 13.9445% which is poor in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Aster DM Healthcare for the current financial year is 19.9152761497621%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Aster DM Healthcare is Rs 123 and the yield is 19.8611%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Aster DM Healthcare is Rs 5.4296. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Aster DM Healthcare in Ticker for free. Also, one can get the intrinsic value of Aster DM Healthcare by using Valuation Calculators, which are available with a Finology ONE subscription. 

Aster DM Healthcare FAQs

Q1. What is Aster DM Healthcare share price today?
Ans: The current share price of Aster DM Healthcare is Rs 617.8.

Q2. What is the market capitalisation of Aster DM Healthcare?
Ans: Aster DM Healthcare has a market capitalisation of Rs 32009.51717162 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Aster DM Healthcare?
Ans: The PE ratio of Aster DM Healthcare is 113.783704140268 and the P/B ratio of Aster DM Healthcare is 8.3524975698261, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Aster DM Healthcare share?
Ans: The 52-week high share price of Aster DM Healthcare is Rs 675, and the 52-week low share price of Aster DM Healthcare is Rs 387.1.

Q5. Does Aster DM Healthcare pay dividends?
Ans: Currently, Aster DM Healthcare pays dividends. Dividend yield of Aster DM Healthcare is around 19.8611%.

Q6. What are the face value and book value of Aster DM Healthcare shares?
Ans: The face value of Aster DM Healthcare shares is Rs 10, while the book value per share of Aster DM Healthcare is around Rs 73.9659. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Aster DM Healthcare?
Ans: Aster DM Healthcare has a total debt of Rs 377.38 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Aster DM Healthcare?
Ans: The ROE of Aster DM Healthcare is 215.569% and ROCE of Aster DM Healthcare is 175.016%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Aster DM Healthcare a good buy for the long term?
Ans: The Aster DM Healthcare long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Aster DM Healthcare undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Aster DM Healthcare appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Aster DM Healthcare’s financials?
Ans: You can review Aster DM Healthcare’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about Aster DM Healthcare

Aster DM Healthcare Ltd Financials: Check Share price, Balance Sheet, Annual report and Quarterly Results for company analysis 

 

Welcome to our stock analysis page for Aster DM Healthcare Ltd. This comprehensive analysis is specifically tailored for Indian long-term stock investors who are seeking detailed insights into the company's performance. In this analysis, we will cover various crucial aspects including share price, balance sheet, annual report, dividend, quarterly result, stock price, price chart, news, con call transcripts, investor presentations, promoters, and shareholders. Additionally, we will highlight ticker pre-built screening tools and premium features, such as DCF Analysis, BVPS Analysis, Earnings multiple approach, and DuPont analysis, which allow for accurate fair value calculation.

Aster DM Healthcare Ltd Share Price Analysis

Discover the share price analysis of Aster DM Healthcare Ltd., which provides key insights into the company's stock performance over time. Our comprehensive analysis allows you to evaluate the relative market performance of the company's stocks compared to industry peers.

Aster DM Healthcare Ltd Balance Sheet Analysis

Evaluate the balance sheet of Aster DM Healthcare Ltd. to gain a better understanding of the company's financial health. Utilize ticker pre-built screening tools and premium features, such as BVPS Analysis and DuPont analysis, to calculate fair value accurately. Assess the company's assets, liabilities, and equity through a comprehensive analysis of its balance sheet.

Aster DM Healthcare Ltd Annual Report Analysis

Access the downloadable annual reports of Aster DM Healthcare Ltd. on Ticker to gain a deeper understanding of the company's overall performance, financial position, and future prospects. These reports provide invaluable insights for long-term stock investors.

Aster DM Healthcare Ltd Dividend Analysis

Analyze the dividend history of Aster DM Healthcare Ltd., including payout ratio and frequency of dividend payments, to gauge the company's commitment to rewarding its shareholders. Our analysis helps you make informed investment decisions based on the company's dividend performance.

Aster DM Healthcare Ltd Quarterly Result Analysis

Stay updated with the quarterly results of Aster DM Healthcare Ltd., which are conveniently available for download on Ticker. Utilize ticker premium features, such as fair value calculation using DCF Analysis and Earnings multiple approach, to comprehensively evaluate the company's financial performance.

Aster DM Healthcare Ltd Stock Price Analysis

Examine in-depth stock price analysis for Aster DM Healthcare Ltd. Monitor market sentiment and identify potential buying or selling opportunities using our comprehensive stock price charts and technical analysis tools. Stay ahead of market trends and make informed investment decisions.

Aster DM Healthcare Ltd Price Chart Analysis

Track the price chart of Aster DM Healthcare Ltd. to gain insights into historical price movements. Our interactive price charts provide a visual representation of the stock's performance, assisting in identifying potential patterns and trends.

Aster DM Healthcare Ltd News Analysis

Stay up-to-date with the latest news related to Aster DM Healthcare Ltd. Our platform provides a comprehensive news section that covers industry updates, company-specific news, and market trends. Stay informed to make well-informed investment decisions.

Aster DM Healthcare Ltd Concall Transcripts

Access the con call transcripts of Aster DM Healthcare Ltd. to gain valuable insights into the company's management perspective and performance outlook. Dive deep into the strategies, future plans, and management responses to questions for a comprehensive analysis.

Aster DM Healthcare Ltd Investor Presentations

Explore Aster DM Healthcare Ltd.'s investor presentations on ticker platform to obtain a structured overview of the company's operations, financial performance, and strategic goals. These presentations provide essential insights for long-term stock investors seeking a comprehensive analysis.

Aster DM Healthcare Ltd Promoters and Shareholders

Access detailed information about Aster DM Healthcare Ltd.'s promoters and major shareholders. Evaluate the confidence and level of involvement of key stakeholders, incorporating this information into your stock analysis. Gain a better understanding of the company's ownership structure.

Aster DM Healthcare Ltd ROCE

Return on Capital Employed (ROCE) is a vital financial metric that assesses a company's efficiency in utilizing its capital to generate profits. On this stock analysis page, investors can find Aster DM Healthcare Ltd's ROCE data in the financials table or ratio section. Understanding the ROCE can provide valuable insights into the company's ability to generate returns on the capital invested in its operations.

Aster DM Healthcare Ltd EBITDA

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is a significant indicator of a company's operating performance and profitability. Aster DM Healthcare Ltd's EBITDA data, available on this page in the financials table or ratio section, offers investors a clear view of the company's ability to generate operating profits before non-operating expenses and non-cash items.

Aster DM Healthcare Ltd DPS

Dividends Per Share (DPS) is a key financial metric that reflects the amount of dividends distributed to shareholders on a per-share basis. Investors can access Aster DM Healthcare Ltd's DPS data on this stock analysis page in the financials table or ratio section to understand the company's dividend distribution policy and its dedication to rewarding shareholders.

Aster DM Healthcare Ltd EPS

Earnings Per Share (EPS) is a fundamental metric representing a company's profitability per outstanding share. By referring to Aster DM Healthcare Ltd's EPS data on this page in the financials table or ratio section, investors can evaluate the company's ability to generate earnings for each share held. Understanding Aster DM Healthcare Ltd's EPS can provide valuable insights into its profitability performance. 

Aster DM Healthcare Share Capital Growth

A closer look at Aster DM Healthcare's balance sheet reveals a notable increase in share capital from Rs 496.80 Cr in March 2020, to Rs 873.90 Cr by March 2023. This change signals the company's expansion efforts and investor confidence in its sustainability.

Aster DM Healthcare Reserves

Aster DM Healthcare saw its reserves fluctuate over the years, with a slight dip in March 2021 at Rs 2,367.07 Cr, then a rise to Rs 2,420.34 Cr by March 2024. The reserves indicate the company's ability to reinvest in its growth and weather economic downturns.

Aster DM Healthcare's Debt Profile

The borrowings of Aster DM Healthcare increased steadily, from Rs 42.71 Cr in March 2020 to Rs 251.21 Cr by March 2024. This evidences the company's reliance on external financing to fuel its operations or expansion plans.

Growth in Aster DM Healthcare Assets

The total assets of Aster DM Healthcare demonstrated consistent growth over the four-year span, climbing to Rs 4,577 Cr by March 2024. Significant investments in net block and current assets are key drivers of this increase, which may suggest strategic asset accumulation for future leverage.

Current Assets Surge at Aster DM Healthcare

There was a remarkable surge in current assets, from Rs 173.09 Cr in March 2020 to Rs 1,769.84 Cr by March 2024. This could point to enhanced liquidity and better short-term financial health of the company.

The data presented is an analysis of the Standalone Balance Sheet of Aster DM Healthcare. While investors incorporate such balance sheet analyses in their decision-making, it is essential to remember that they also consider other factors such as stock performance, market trends, and sectoral shifts.

Read More
X